Harvard Bioscience (HBIO) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.70% |
| Dec 31, 2025 | -20.53% |
| Sep 30, 2025 | -54.40% |
| Jun 30, 2025 | 19.07% |
| Mar 31, 2025 | 19.63% |
| Dec 31, 2024 | -15.70% |
| Sep 30, 2024 | -41.15% |
| Jun 30, 2024 | -9.18% |
| Mar 31, 2024 | 15.32% |
| Dec 31, 2023 | -20.52% |
| Sep 30, 2023 | 3.66% |
| Jun 30, 2023 | 105.67% |
| Mar 31, 2023 | -9.80% |
| Dec 31, 2022 | 28.94% |
| Sep 30, 2022 | -12.93% |
| Jun 30, 2022 | -55.29% |
| Mar 31, 2022 | -16.40% |
| Dec 31, 2021 | 10.80% |
| Sep 30, 2021 | -18.62% |
| Jun 30, 2021 | 21.38% |
| Mar 31, 2021 | -1.37% |
| Dec 31, 2020 | 136.42% |
| Sep 30, 2020 | 15.65% |
| Jun 30, 2020 | -29.99% |
| Mar 31, 2020 | 14.21% |
| Dec 31, 2019 | 16.10% |
| Sep 30, 2019 | 7.59% |
| Jun 30, 2019 | -19.03% |
| Mar 31, 2019 | -157.11% |
| Dec 31, 2018 | 16.41% |
| Sep 30, 2018 | -12.29% |
| Jun 30, 2018 | -72.87% |
| Mar 31, 2018 | -16.33% |
| Dec 31, 2017 | -60.29% |
| Sep 30, 2017 | -1.44% |
| Jun 30, 2017 | -16.14% |
| Mar 31, 2017 | -29.82% |
| Dec 31, 2016 | -6.84% |
| Sep 30, 2016 | 18.94% |
| Jun 30, 2016 | -18.92% |
| Mar 31, 2016 | -48.90% |
| Dec 31, 2015 | -15.16% |
| Sep 30, 2015 | -30.65% |